Fasudil for cognitive dysfunction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Apr 2024: Trial registered, NCT06362707
  2. 1 Aug 2024: Trial started, NCT06362707

The trials

NCT06362707: Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

State
Under way
Phase
Phase 2
People
200 planned
Started
1 Aug 2024
Primary completion
1 Jan 2028
Arms
Fasudil
Results
None posted
  1. 12 Apr 2024: Trial registered
  2. 1 Aug 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.